Hyderabad Telangana, India

Mahesh Kumar Gadakar

This inventor holds 1 USPTO granted patent. Top assignee: Mylan Laboratories Limited. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahesh Kumar Gadakar. Retrieved from https://idiyas.com/inventor/mahesh-kumar-gadakar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mahesh Kumar Gadakar: Innovator in Pharmaceutical Patents

Introduction

Mahesh Kumar Gadakar is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on cabozantinib.

Latest Patents

Gadakar holds a patent for "Polymorphs of cabozantinib (S)-malate and cabozantinib free base." This patent presents novel crystalline forms of cabozantinib (S)-malate, designated as form-M, M, Mand M, along with novel crystalline forms of cabozantinib free base, form-M, Mand M. The disclosure also includes methods for their production and processes for preparing crystalline cabozantinib (S)-malate form N-1. He has 1 patent to his name.

Career Highlights

Mahesh Kumar Gadakar is currently employed at Mylan Laboratories Limited, where he continues to advance his research and development efforts in the pharmaceutical sector. His work has been instrumental in enhancing the understanding and application of cabozantinib.

Collaborations

Gadakar has collaborated with notable colleagues, including Ramakoteswara Rao Jetti and Anjaneyaraju Indukuri, contributing to a dynamic research environment.

Conclusion

Mahesh Kumar Gadakar's innovative contributions to pharmaceutical patents, particularly in the area of cabozantinib, highlight his role as a key figure in the industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…